Skip to content

Acetazolamide and Topiramate on patients with traumatic cerebrospinal fluid leakage

Comparing the effect of Acetazolamide and Topiramate on patients with traumatic cerebrospinal fluid leakage

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221108056446N4
Enrollment
120
Registered
2023-11-15
Start date
2022-12-22
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Trauma. Diffuse traumatic brain injury

Interventions

Intervention 1: Intervention group: They receive 1 gram of acetazolamide in oral form every 24 hours, which will continue for 5-7 days. Intervention 2: Control group: They receive 100 mg topiramate or

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient consent to enter the study The patient's non-use of Tricyclic Antidepressants and carbonic anhydrase inhibitor in order to prevent drug interactions.

Exclusion criteria

Exclusion criteria: Patients who develop meningitis and brain abscess Patients with severe electrolyte disturbances Patients who do not respond to treatment and have to use brain surgery Patients who did not respond to drug therapy after one week and another intervention should be performed on them Failure to visit the patient for follow-up Kidney and liver patients who are suffering from a specific disease based on the diagnosis of a specialist and are listed in the patient's medical record

Design outcomes

Primary

MeasureTime frame
Cerebrospinal fluid leakage. Timepoint: Patients are evaluated weekly using a checklist and up to three months after discharge from the hospital. Method of measurement: Checklist and measurement of GCS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Mahmoodkhani

Esfahan University of Medical Sciences

mahmoodkhani@med.mui.ac.ir+98 31 3233 0091

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026